282
Views
114
CrossRef citations to date
0
Altmetric
Original Article

Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008

, , , , , & show all
Pages 1-10 | Published online: 12 Nov 2013

References

  • Agency for Toxic Substances and Disease Registry. Asbestos: health effects. http://www.atsdr.cdc.gov/asbestos/asbestos/health_effects/.
  • King C, Mayes D, Dorsey DA. Benign asbestos-related pleural disease. Dis Mon. 2011;57(1):27–39.
  • Kamp DW. Asbestos-induced lung diseases: an update. Transl Res. 2009;153(4):143–52.
  • International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: Volume 100C: a review of human carcinogens: arsenic, metals, fibres, and dusts. Lyon: International Agency for Research on Cancer; 2011.
  • National Toxicology Program. Report on carcinogens. 12th ed. Research Triangle Park, NC: US Department of Health and Human Services, Public Health Service, National Toxicology Program; 2011.
  • Sovak M, Aisner S, Aisner J. Tumors of the pleura and mediastinum. In: Abeloff M, OArmitage J, Niederhuber J, Kastan M, McKenna W, editors. Abelhoff’s clinical oncology. Philadelphia, PA: Churchill Livingstone Elsevier; 2008. p. 1367–98.
  • Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44(8):565–601.
  • Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999;56(8):505–13.
  • Selikoff IJ, Hammond EC. Asbestos-associated disease in United States shipyards. CA Cancer J Clin. 1978;28(2):87–99.
  • Virta R. Worldwide asbestos supply and consumption trends from 1900 through 2003. Vol Circular 1298. Reston, VA: US Geological Survey; 2006. http://pubs.usgs.gov/circ/2006/1298/c1298.pdf.
  • Virta R. Mineral commodity summaries 2012. Reston, VA: US Geological Survey; 2012. http://minerals.usgs.gov/minerals/pubs/commodity/asbestos/index.html#mcs.
  • Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al.. SEER cancer statistics review 1975–2008. Bethesda, MD: National Cancer Institute; 2011. http://seer.cancer.gov/csr/1975_2008/.
  • Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results program data for 1973 through 2003. Am J Epidemiol. 2004;159(2):107–12.
  • Price B, Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 2009;39(7):576–88.
  • Moolgavkar SH, Meza R, Turim J. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005. Cancer Causes Control. 2009;20(6):935–44.
  • Larson T, Melnikova N, Davis SI, Jamison P. Incidence and descriptive epidemiology of mesothelioma in the United States, 1999–2002. Int J Occup Environ Health. 2007;13(4):398–403.
  • US Cancer Statistics Working Group. United States Cancer Statistics: 1999–2008 incidence and mortality web-based report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2011. www.cdc.gov/uscs.
  • Fritz A, Percy C, Jack A, Parkin D M, Shanmugarathan S, Sobin L, et al.. editors. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
  • National Cancer Institute. Surveillance Epidemiology and End Results (SEER) Program. Population estimates used in NCI’s SEER*Stat software. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/popdata/methods.html.
  • Centers for Disease Control and Prevention. National Vital Statistics System. US census populations with bridged race categories. http://www.cdc.gov/nchs/about/major/dvs/popbridge/popbridge.htm.
  • Anderson R, Rosenberg H. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep. 1998;47(3):1–16.
  • Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15(6):547–69.
  • NAACCR Latino Research Work Group. NAACCR guideline for enhancing Hispanic/Latino identification: revised NAACCR Hispanic/Latino identification algorithm [NHIA v2.1]. Springfield, IL: North American Association of Central Cancer Registries; 2008.
  • Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.
  • Wingo PA, Jamison PM, Hiatt RA, Weir HK, Gargiullo PM, Hutton M, et al.. Building the infrastructure for nationwide cancer surveillance and control — a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control. 2003;14(2):175–93.
  • Merrill RM, Dearden KA. How representative are the Surveillance, Epidemiology, and End Results (SEER) program cancer data of the United States? Cancer Causes Control. 2004;15(10):1027–34.
  • Lin R-T, Takahashi K, Karjalainen A, Hoshuyama T, Wilson D, Kameda T, et al.. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet. 2007;369(9564):844–9.
  • Nishikawa K, Takahashi K, Karjalainen A, Wen CP, Furuya S, Hoshuyama T, et al.. Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment. Environ Health Perspect. 2008;116(12):1675–80.
  • Tossavainen A. Global use of asbestos and the incidence of mesothelioma. Int J Occup Environ Health. 2004;10(1):22–5.
  • Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ. 2011;89(10):716–24724A–C.
  • Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, et al.. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol. 2012;227(1):44–58.
  • Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for asbestos (TP-61). Atlanta, GA: US Department of Health and Human Services, Public Health Service; 2001.
  • Concha-Barrientos M, Nelson D, Driscoll T, Steenland NK, Punnett L, Fingerhut MA, et al.. Selected occupational risk factors. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of disease attribution to selected major risk factors. Geneva: World Health Organization; 2004.
  • US Department of Health, Education, and Welfare. Revised recommended asbestos standard. DHEW NIOSH Publication No. 77–169. Washington, DC: US Department of Health, Education, and Welfare, Centers for Disease Control, National Institute for Occupational Safety and Health; 1976.
  • Occupational Safety and Health Administration. Occupational exposure to asbestos, tremolite, anthophyllite and actinolite. Washington, DC: Occupational Safety and Health Administration; 1996.
  • Olsen NJ, Franklin PJ, Reid A, de Klerk NH, Threlfall TJ, Shilkin K, et al.. Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation. Med J Aust. 2011;195(5):271–4.
  • Jemal A, Grauman D, Devesa S. Recent geographic patterns of lung cancer and mesothelioma mortality rates in 49 shipyard counties in the United States, 1970–94. Am J Ind Med. 2000;37(5):512–21.
  • National Institute for Occupational Safety and Health. The work-related lung disease surveillance report, 2002. Vol. DHHS (NIOSH) number 2003–111. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Division of Respiratory Disease Studies; 2003.
  • Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, et al.. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ Health Perspect. 2003;111(14):1753–9.
  • Antao VC, Larson TC, Horton DK. Libby vermiculite exposure and risk of developing asbestos-related lung and pleural diseases. Curr Opin Pulm Med. 2012;18(2):161–7.
  • International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 14. A review of human carcinogens: asbestos. Lyon: International Agency for Research on Cancer; 1977.
  • Kane MJ, Chahinian AP, Holland JF. Malignant mesothelioma in young adults. Cancer. 1990;65(6):1449–55.
  • Zarogoulidis P, Orfanidis M, Constadinidis TC, Eleutheriadou E, Kontakiotis T, Kerenidi T, et al.. A 26-year-old male with mesothelioma due to asbestos exposure. Case Report Med. 2011;2011:951732.
  • Bitchatchi E, Kayser K, Perelman M, Richter ED. Mesothelioma and asbestosis in a young woman following occupational asbestos exposure: short latency and long survival: Case report. Diagn Pathol. 2010;5:81.
  • Cioffredi L-A, Jänne PA, Jackman DM. Treatment of peritoneal mesothelioma in pediatric patients. Pediatr Blood Cancer. 2009;52(1):127–9.
  • Vinikoor LC, Larson TC, Bateson TF, Birnbaum L. Exposure to asbestos-containing vermiculite ore and respiratory symptoms among individuals who were children while the mine was active in Libby, Montana. Environ Health Perspect. 2010;118(7):1033–8.
  • Kilburn KH, Lilis R, Anderson HA, Boylen CT, Einstein HE, Johnson SJ, et al.. Asbestos disease in family contacts of shipyard workers. Am J Public Health. 1985;75(6):615–7.
  • Reid A, Franklin P, Olsen N, Sleith J, Samuel L, Aboagye-Sarfo P, et al.. All-cause mortality and cancer incidence among adults exposed to blue asbestos during childhood. Am J Ind Med. e-pub ahead of print 2012 Aug 9. doi:10.1002/ajim.22103.
  • Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18(6):985–90.
  • Marinaccio A, Binazzi A, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, et al.. Incidence of extrapleural malignant mesothelioma and asbestos exposure, from the Italian national register. Occup Environ Med. 2010;67(11):760–5.
  • Mensi C, Bonzini M, Macchione M, Sieno C, Riboldi L, Pesatori AC. Differences among peritoneal and pleural mesothelioma: data from the Lombardy Region Mesothelioma Register (Italy). Med Lav. 2011;102(5):409–16.
  • Carbone M, Yang H. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin Cancer Res. 2011;18(3):1–7.
  • Goldberg S, Rey G, Luce D, Gilg Soit Ilg A, Rolland P, Brochard P, et al.. Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates. Occup Environ Med. 2010;67(6):417–21.
  • Boffetta P, Stayner L. Pleural and peritoneal neoplasms. In: , Schottenfeld D, Fraumeni J F, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 659–73.
  • Maule MM, Magnani C, Dalmasso P, Mirabelli D, Merletti F, Biggeri A. Modeling mesothelioma risk associated with environmental asbestos exposure. Environ Health Perspect. 2007;115(7):1066–71.
  • Kurumatani N, Kumagai S. Mapping the risk of mesothelioma due to neighborhood asbestos exposure. Am J Respir Crit Care Med. 2008;178(6):624–9.
  • Hansell A. Airborne environmental exposure to asbestos. Am J Respir Crit Care Med. 2008;178(6):556–7.
  • Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study. Br J Cancer. 2009;100(7):1175–83.
  • Strauchen JA. Rarity of malignant mesothelioma prior to the widespread commercial introduction of asbestos: The Mount Sinai autopsy experience 1883–1910. Am J Ind Med. 2011;54(6):467–9.
  • US Environmental Protection Agency. Asbestos ban and phaseout. 2010. http://www.epa.gov/asbestos/pubs/ban.html.
  • Virta R. 2010 minerals yearbook: asbestos. Reston, VA: US Geological Survey; 2011. http://minerals.usgs.gov/minerals/pubs/commodity/asbestos/myb1-2010-asbes.pdf.
  • Campbell NP, Kindler HL. Update on malignant pleural mesothelioma. Semin Respir Crit Care Med. 2011;32(1):102–10.
  • World Health Organization. Elimination of asbestos-related diseases. 2006. http://whqlibdoc.who.int/hq/2006/WHO_SDE_OEH_06·03_eng.pdf.
  • LaDou J, Castleman B, Frank A, Gochfeld M, Greenberg M, Huff J, et al.. The case for a global ban on asbestos. Environ Health Perspect. 2010;118(7):897–901.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.